Page results
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy). We provide multidisciplinary care for patients who are referred from their GP or from other hospitals. Although immune-related neurotoxicity is relatively rare it may be severe and is associated with significant disability and high risk to patients if not recognised and managed promptly and well.
-
EMIS outage caused backlog of result messages via Keystone
-
Contact phone and email numbers for University College London Hospitals NHS Foundation Trust.
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
-
Information about hyperthermic intraperitoneal chemotherapy (HIPEC), including about the risks and benefits, and alternatives to the treatment.
File results
-
FOI/2021/0559 - Department of Respiratory Physiology recall letter
-
FOI/2021/0572 - Dermatological and rheumatological conditions
-
FOI/2021/0577 - Patient brought to A&E paralysed
-
FOI/2021/0591 - Laboratory/ Pathology information system
-
FOI/2021/0593 - Contact centre/ Call centre contract
-
FOI/2021/0601 - Treatment Guidelines with Systemic lupus erythematosus (SLE) / Lupus nephritis (LN)
-
FOI/2021/0616 - Overseas visitors and migrants
-
FOI/2021/0618 - Number of patient admissions to A&E
-
FOI/2021/0626 - Cardiac output monitors and manufacturer associated disposable products
-
FOI/2021/0100 - DNACPR orders issued - March 2019 to January 2021